GLP-1 Under $300 Per Month: Which Options Actually Stay Under $300 in 2026?
The 60-second answer
Last verified:A GLP-1 under $300 per month is real in 2026 — if you know which programs hold the line after month one. Most "starting at $149" ads become $299+ by month three once dose escalation and membership fees kick in. We verified 14 programs against their public pricing pages on April 24, 2026, then applied the $300 Cap Test: does the all-in monthly cost — medication, membership, and a realistic dose — still sit under $300 beyond the intro window?
| If you want this | Your pick | Verified monthly cost |
|---|---|---|
| Cleanest broad compounded path | Eden (semaglutide, 3-month plan) | $129 first month, then $209/mo |
| FDA-approved without telehealth membership | NovoCare Pharmacy (Wegovy® pill) | $149/mo at 1.5mg and 4mg doses |
| FDA-approved telehealth under $300 | Ro + Foundayo™ — annual prepay | $188 first month; $273–$373/mo ongoing with annual prepay |
| No-contract $299 ceiling | MEDVi (compounded semaglutide) | $179 first month, $299/mo refills |
| Needle-free compounded | SHED (lozenges or drops) | $199–$229/mo |
| Already have a prescription | Amazon One Medical renewals | From $29 renewal visit + med |
| Not sure which lane fits | Free matching quiz | No cost, 60 seconds |
| Prices verified April 24, 2026. The Ro + Foundayo path passes at lower and middle dose tiers with annual prepay — not at higher doses. Re-verify at checkout before paying. | ||
One more line of honesty on the Ro + Foundayo path: on monthly membership, it doesn't hold under $300 ongoing. With annual prepay ($74/mo effective membership) + Foundayo medication ($149–$299 depending on dose), you land between $273 and $373. It passes the cap at the lower and middle dose tiers with annual prepay — not above.
Not sure which lane fits you?
The honest way to avoid the programs that won't hold your budget past month three.
Take the 60-second matching quizCan you really get a GLP-1 under $300 per month?
There are three real lanes at this budget. If you don't know which one you belong in, the rest of this page is wasted on you — so start here.
Compounded semaglutide (where most under-$300 buyers land)
Compounded semaglutide is prepared by a licensed pharmacy — either a state-licensed 503A pharmacy (compounds one prescription at a time for one patient) or a federally registered 503B outsourcing facility (compounds in larger batches under stricter federal oversight). Compounded products are not FDA-approved as finished products. The FDA does not review them for safety, effectiveness, or quality before they reach you.
After the FDA confirmed the semaglutide injection shortage was resolved in February 2025, the compounding rules tightened. 503A pharmacies had until April 22, 2025 to wind down shortage-era compounding; 503B outsourcing facilities had until May 22, 2025. In March 2026, the FDA issued warning letters to 30+ telehealth companies for misleading compounded GLP-1 marketing.
Who this fits: self-pay shoppers who understand what "not FDA-approved" means and are comfortable with it.
FDA-approved oral GLP-1 at a lower dose
The oral era changed this math. Two FDA-approved oral GLP-1 medications now start at $149/month at low doses through manufacturer-direct programs: the Wegovy® pill (oral semaglutide, FDA-approved December 2025) and Foundayo™ (orforglipron, FDA-approved April 1, 2026). Both manufacturers — Novo Nordisk and Eli Lilly — list $149/mo at their starter dose tiers.
Who this fits: anyone who requires FDA-approved medication, is fine with a pill instead of an injection, and doesn't need tirzepatide-level efficacy.
Intro-price injectables (the danger zone)
This is where most budget shoppers get burned. "Starting at $149" often means first month only. By month two, the same program may cost $299–$499. Wegovy® injection cash-pay through NovoCare Pharmacy is $199/month for the 0.25mg and 0.5mg starter doses — through June 30, 2026 only — then $349/month. Compounded tirzepatide almost always breaks the $300 cap at maintenance dose.
Who this fits: readers who understand the second-month math and are OK with it — not readers who need the first-month price to be the real price.
Want to know which programs actually hold the line? The Under-$300 Reality Matrix is the table most pages don't publish.
The $300 Cap Test: our methodology
Last verified:
Most "cheapest GLP-1" lists rank by advertised starting price. That's the wrong number. The starting price is month one. The number that matters is month three, when your dose is climbing and the intro is gone. Here's how we weight it:
| Factor | Weight | What it measures |
|---|---|---|
| Under-$300 integrity | 40% | Does the monthly cost stay under $300 after the first month, after membership, after a likely dose increase? |
| Price transparency | 20% | Is the full cost shown at checkout — medication, membership, shipping, labs, consult — without digging through FAQs? |
| Medical and regulatory clarity | 15% | Does the provider clearly label compounded vs. FDA-approved? No blurring allowed. Has the provider received FDA warning letters relevant to compounded GLP-1 marketing? |
| Fit segmentation | 15% | Does the program win for a clearly defined buyer type rather than pretending to win for everyone? |
| Friction | 10% | Plan commitments, cancellation windows, refill rules, state exclusions, hidden prepay requirements. |
How to read the matrix labels
Verified public price stays under $300/month in at least the typical use case.
Passes only with specific conditions — annual prepay, 3-month plan, lower dose, existing prescription, etc.
Starts under $300 but has a documented second-month price that exceeds the cap.
Doesn't fit this page even with gymnastics.
A public claim conflicts with another source or couldn't be confirmed at checkout.
The Under-$300 Reality Matrix
Last verified:Prices verified against each provider's public pricing page on April 24, 2026. We cross-checked manufacturer-direct prices against NovoCare Pharmacy and LillyDirect. Every price should be re-verified at checkout before you pay.
| # | Provider | Route | Month 1 | Month 2+ / Ongoing | $300 Cap Test | Who it fits |
|---|---|---|---|---|---|---|
| 1 | Eden | Compounded semaglutide (3-month plan) | $129 | $209/mo | 🟢PassHolds under $300 across every dose with Eden's stated same-price guarantee | Broad compounded default |
| 2 | Eden | Compounded tirzepatide | $249 | $329/mo | 🔴Above capTirzepatide pricing exceeds $300/mo | Not this page |
| 3 | MEDVi | Compounded semaglutide (injection) | $179 | $299/mo refill | 🟡ConditionalPasses at $299 ceiling; read FDA warning letter disclosure below | No-contract buyers who verify and read the disclosure |
| 4 | MEDVi | Compounded tirzepatide | $279–$349 | $399+/mo refill | 🔴Above cap | Not this page |
| 5 | NovoCare Pharmacy direct | Wegovy® pill (1.5mg, 4mg doses) | $149 | $149/mo at 1.5mg and 4mg; 4mg rises to $199 after Aug 31, 2026 | 🟢PassNo telehealth membership required; bring your own prescriber | Existing-prescriber, FDA-approved oral |
| 6 | Ro + Foundayo™ | FDA-approved orforglipron — monthly membership | $188 ($39 + $149 med) | $348–$448/mo ($149 membership + $199–$299 med by dose) | 🟠Intro onlyMonthly billing exceeds cap | Not this path |
| 7 | Ro + Foundayo™ | FDA-approved orforglipron — annual membership | $188 ($39 + $149 med) | $273–$373/mo ($74 eff. membership + $199–$299 med by dose) | 🟡ConditionalPasses at starter and mid doses with annual prepay | FDA-approved telehealth under $300 |
| 8 | Ro + Wegovy® pill | FDA-approved oral semaglutide via telehealth | $188 ($39 + $149 med) | $149 membership + $149–$299 med by dose | 🟡ConditionalDirect NovoCare is the cleaner FDA-approved pill path at lower doses | Readers who also want insurance concierge |
| 9 | Ro + Zepbound® vials | FDA-approved tirzepatide | $338+ ($39 + $299 vial) | $448+/mo at 5mg vial | 🔴Above capAbove cap at all doses | Not this page |
| 10 | SHED | Compounded GLP-1 lozenges (oral) | $199 | Starting at $199/mo | 🟢Pass | Needle-free, compounded |
| 11 | SHED | Compounded GLP-1 liquid drops | $229 | Starting at $229/mo | 🟢Pass | Needle-free, compounded |
| 12 | SHED | Compounded semaglutide injection | Conflicting ($199 vs. $299) | Conflicting | ⚪Needs verificationVerify exact product and price at checkout | Not ranked until resolved |
| 13 | Sesame + NovoCare | FDA-approved Wegovy® via NovoCare Pharmacy | $258 ($59 annual + $199 starter med) | $429 ongoing ($59 + $349) | 🟠Intro onlyStarter window through 6/30/26, then exceeds cap | Starter-dose shoppers; not long-term under $300 |
| 14 | Amazon One Medical | FDA-approved renewals / oral paths | $29 renewal + med | Varies; oral from $149, injectables from $299 | 🟡ConditionalOral and renewal paths fit; injectables sit at the cap | Already-have-prescription users, renewals |
| 15 | Willow | Compounded semaglutide | $299/mo subscription | $299/mo | 🟡ConditionalExactly at cap with subscription; verify before committing | Backup only |
| 16 | bmiMD | Compounded tirzepatide plans | 12-mo: $249.30/mo · 6-mo: $269.10/mo · 3-mo: $298.80/mo · monthly: $349.20/mo | Same, by plan length | 🟡ConditionalPasses only with 3-month or longer prepay | Prepay-tolerant tirzepatide shoppers |
| 17 | MyStart Health | Compounded semaglutide | Starts at $299/mo (per public FAQ) | $299/mo | ⚪Needs verificationRegulatory disclosure — see note below | See disclosure below before considering |
| The "Ongoing" column is the number that matters. 🟢/🟡 fits under $300 in at least one realistic scenario. 🟠 looks good in month one and stops fitting by month three. 🔴 don't waste time on this page. ⚪ don't decide until verified. Prices verified April 24, 2026 — re-verify at checkout. | ||||||
A disclosure on MyStart Health
We initially considered MyStart Health based on third-party reviews citing a $149/month 3-month plan. MyStart's own public FAQ states the program "starts at $299/month, excluding any discounts." More importantly, the FDA issued MyStart Health LLC a warning letter on September 9, 2025 citing false or misleading compounded semaglutide claims — including "Generic Ozempic" and claims that compounded versions have "the same active ingredients and results" as FDA-approved products. Until current checkout pricing and marketing corrections are verified, MyStart does not belong in the pass set.
What breaks the $300 budget after you start
The 7 hidden budget-breakers
| Break | What it looks like | Where it happens | How to protect yourself |
|---|---|---|---|
| First-month promo | $129, $149, $179, $199 — a discount that ends after month one | Most intro programs | Ask for month-two and month-three price before paying |
| Membership separate from medication | "Starting at $149" for meds, $39–$149 on top for care membership | Ro, Amazon One Medical, Sesame | Add membership + medication together before comparing |
| Dose escalation pricing | Medication cost scales with dose (0.25mg → 2.4mg for semaglutide, 2.5mg → 15mg for tirzepatide) | Ro + Foundayo, most compounded tirzepatide programs | Ask: "Does my price change if my dose increases?" |
| Refill-window rules | Lower price requires refill within a set window; miss it and the discount expires | NovoCare Wegovy/Ozempic starter windows (end June 30, 2026) | Set a calendar alert; confirm policy in writing |
| Annual-prepay fine print | "As low as $74/month" requires paying a full year upfront | Ro Body annual prepay | Calculate monthly math and annual math separately |
| Required labs or shipping | Not always included in the headline price | Varies by provider | Ask what's bundled and what's extra before checkout |
| Cancellation friction | Orders sent to the pharmacy may not be cancellable; auto-renew before you catch it | MEDVi (72-hour window), SHED (2-month minimum) | Read cancellation terms before your first refill ships |
The rule that saves most readers
Compare the second-month price, not the first-month price. If a program won't tell you month two's cost clearly, that's your answer — go somewhere that will. Every program we featured in the pass or conditional rows above publishes both numbers.
Dose escalation: the table nobody else publishes
Most programs price by milligrams dispensed. Pharmacies pay more for more medication; that gets passed on to you. Some programs guarantee a flat price at every dose. Most don't.
| Provider | Starter dose price | Mid-dose price | Max dose price | Price stays flat? |
|---|---|---|---|---|
| Eden (compounded semaglutide) | $209/mo | $209/mo | $209/mo | ✅ Same price every dose (provider-stated) |
| MEDVi (compounded semaglutide) | $179 first, $299 refills | $299/mo | $299/mo | ✅ Flat at the $299 refill ceiling |
| SHED (lozenges) | Starting at $199/mo | Verify at checkout | Verify at checkout | Provider-stated "starting at" — confirm dose-by-dose at intake |
| SHED (drops) | Starting at $229/mo | Verify at checkout | Verify at checkout | Provider-stated "starting at" — confirm dose-by-dose at intake |
| Ro + Foundayo™ | $149/mo med at starter | $199/mo med (Foundayo dose 2) | $299/mo med (higher dose) | ❌ No — scales with Foundayo dose |
| Ro + Wegovy® pill | $149/mo med | $199/mo med (Wegovy 4mg after 8/31/26) | $299/mo med | ❌ No — scales with dose |
| NovoCare direct (Wegovy® pill) | $149/mo (1.5mg and 4mg) | $149/mo (through 8/31/26) | Higher at 9mg and 25mg | ❌ Flat only at lower dose tiers |
| Most compounded tirzepatide programs | $249–$349/mo | $349–$449/mo | $449+/mo | ❌ Common pattern: pricing scales with dose |
| Dose escalation is the single biggest reason budgets break. The same-price-every-dose programs — Eden and MEDVi — protect you across every dose tier. Source: provider public pricing pages, April 2026. | ||||
"I want same-price-every-dose protection so my budget doesn't blow up when I titrate."
Check Eden's current semaglutide pricing and eligibility →Best picks under $300/month: segmented by your situation
Most buyers fall into one of five lanes. The right program depends on which lane you're in — not on what ranks #1 on every listicle.
Eden
Why Eden passes the $300 Cap Test at every dose
- Public compounded semaglutide pricing: $129 first month, $209/mo on the 3-month plan
- No separate care membership fee layered on top
- Same-price-every-dose guarantee (provider-stated, uncommon in compounded telehealth)
- Eden ships through certified, state-licensed pharmacies — ask which pharmacy fills yours at intake
- Compounded semaglutide, compounded tirzepatide, and brand-name Wegovy/Zepbound all available — start compounded and switch later without leaving the platform
- HSA and FSA cards accepted for visits and prescriptions (confirm your plan covers the expense)
Honest tradeoffs
- Compounded medications are not FDA-approved. The FDA does not review them for safety, effectiveness, or quality.
- No insurance accepted directly
- State availability varies — verify at intake before paying
- Eden's compounded tirzepatide runs $329/month ongoing — it does not pass the $300 cap. If you specifically want tirzepatide, see MEDVi or compare compounded tirzepatide separately.
Damaging admission + pivot
Eden is not the cheapest sticker price on this page. MEDVi's first month is $179. NovoCare direct gets you FDA-approved Wegovy® pill at $149/mo — cheaper than Eden on medication alone. But because Eden's $209 stays the same whether you're on 0.25mg or 2.0mg, the person who starts at a low dose and titrates up will usually pay less total over 12 months than at a program that raises the price at higher doses. For most people who want compounded semaglutide and plan to titrate, Eden wins the math.
"I want a clean under-$300 compounded semaglutide plan with no price surprises when I titrate up."
Check Eden's current semaglutide pricing and eligibility →NovoCare Pharmacy direct (Wegovy® pill)
Why this path passes cleanly
- $149/mo is the medication total — no membership to add
- FDA-approved means the finished product has been reviewed by the FDA for safety, effectiveness, and quality
- Shipped by NovoCare Pharmacy (Novo Nordisk's direct-to-patient pharmacy)
- Works if you already have a prescribing clinician — ask them to send the prescription to NovoCare
Honest tradeoffs
- You need a prescriber. If you don't have one, you'll need to pair this with telehealth.
- $149 pricing is specific to the 1.5mg and 4mg doses. Higher doses price higher.
- The 4mg $149 window closes August 31, 2026 — then rises to $199/mo.
- Clinical trials of oral Wegovy showed approximately 14% mean body weight loss over 64 weeks when combined with lifestyle changes.
"I want FDA-approved medication, I have a prescriber, and I want the cheapest path."
See NovoCare Pharmacy Wegovy® pill pricingRo + Foundayo™ (orforglipron) — with annual prepay
Why Ro + Foundayo is the best FDA-approved telehealth fit under $300
- Foundayo is priced at $149/mo at the starter dose, matching LillyDirect's direct pricing
- Ro Body annual prepay drops the effective membership to $74/mo
- Includes a dedicated insurance concierge that handles prior-authorization paperwork
- Includes Ro's free GLP-1 Insurance Coverage Checker
- FDA-approved means the finished medication has been reviewed by the FDA for safety, effectiveness, and quality
- Ro also carries the Wegovy® pill ($149/mo starter dose)
Foundayo safety — read before checking eligibility
Foundayo is not for use alongside other GLP-1 receptor agonist medications. Like other GLP-1s, Foundayo's label warns about thyroid tumor risk; do not use Foundayo if you or a family member has a personal or family history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN2). Trial data from ATTAIN-1 showed approximately 12.4% average weight loss for participants who stayed on treatment — lower than tirzepatide and injectable semaglutide at maintenance dose. Ro's intake will screen for contraindications — answer honestly.
Honest tradeoffs
- Ro Body membership is mandatory and does not include medication. Some buyers find this confusing at checkout.
- Monthly membership ($149) + higher Foundayo doses ($299) pushes the total above $300. Annual prepay is how this path survives.
- Zepbound vials through Ro do not pass the cap at any dose.
Damaging admission + pivot
Ro is not the lowest sticker price on this page. Eden ($209/mo compounded) and NovoCare direct ($149/mo for Wegovy pill with your own prescriber) both undercut it. If you already have a prescriber, NovoCare direct is cheaper. If you want compounded, Eden is cheaper. If you want FDA-approved plus telehealth support, Ro + Foundayo with annual prepay is the path.
"I want FDA-approved medication plus telehealth support, I'll commit to annual prepay, and I'll start at the lower dose tiers."
Check Foundayo™ eligibility at Ro — $39 first month →Best no-contract $299 ceiling: MEDVi (read the FDA letter disclosure first)
⚠ Material FDA disclosure
On February 20, 2026, the FDA issued a warning letter to MEDVi, LLC (letter #721455). The FDA cited false or misleading website claims and misbranding — specifically claims that MEDVi's compounded products had "the same active ingredient as Wegovy® and Ozempic®" and "the same active ingredient as Mounjaro® and Zepbound®." The letter addressed website marketing and labeling. It did not report a patient-harm finding or a lot-specific safety finding. For context, the FDA issued similar warning letters to more than 30 telehealth companies in early 2026 for related violations. MEDVi continues to operate under LegitScript certification and works with licensed pharmacies through the OpenLoop Health provider network.
Why MEDVi still belongs on this page
- Public $179/$299 pricing structure, no contract, no separate membership fee
- Month-to-month billing with a 72-hour cancellation window before next billing cycle
- Deepest compounded menu verified — semaglutide and tirzepatide in both injection and oral tablet formats
- Includes physician evaluation, personalized care plan, metabolic report, unlimited messaging, and shipping
- LegitScript certified as of April 2026 (third-party verification)
Damaging admission + pivot
If MEDVi's FDA warning letter makes you uncomfortable, Eden is the cleaner compounded choice — slightly higher first-month price ($129 vs. $179), same compounded semaglutide medication class, no FDA warning letter history at the time of this review. Use the Reality Matrix above to decide which tradeoff you want.
"I want a no-contract, month-to-month $299 ceiling — and I've read the warning letter disclosure."
Verify MEDVi's current $299 refill terms →Best needle-free under $300: SHED (lozenges and drops)
Why SHED wins the needle-free lane
- Widest format variety verified: injections, sublingual drops (absorbed under the tongue), dissolvable lozenges, liposomal oral tablets
- Starting prices publicly stated for lozenges and drops
- Money-back guarantee: eligible users who complete nine months and fully comply may qualify for a refund or program credit (read the terms)
- Also carries FDA-approved Foundayo® — verify current price and dose options at intake
Honest tradeoffs
- Compounded oral and sublingual GLP-1s have less clinical efficacy research than injections — the STEP and SURMOUNT trials studied injectable formulations
- Two-month minimum commitment
- Cancellation requires 72-hour notice before next billing cycle
- SHED's compounded semaglutide injection pricing needs checkout verification
- Dose-flat pricing on lozenges and drops is provider-stated "starting at" — confirm your specific dose price at intake
"I want the cheapest needle-free compounded GLP-1 and I'll verify the specific product and dose at intake."
See if SHED's oral GLP-1 options fit your situation →Best if you already have a prescription: Amazon One Medical
- $29 renewal visit for existing prescriptions is the cheapest provider touch verified
- Oral pill paths (Wegovy pill) at $149/month match manufacturer-direct pricing
- Clean, simple workflow for buyers who just need refill infrastructure
Not built for first-time prescriptions. If you're starting from scratch, Ro or Eden are better paths. Injectable cash-pay at $299 sits right at the cap — no margin for error. Renewals require existing prescription within the past two weeks and no dose titration.
Can you get FDA-approved GLP-1 medication under $300 per month?
Last verified:Foundayo™ (orforglipron) — the newest FDA-approved oral GLP-1
NEW — FDA-approved April 1, 2026Foundayo was approved by the FDA on April 1, 2026, as an oral once-daily GLP-1 receptor agonist. It comes in 0.8mg, 2.5mg, 5.5mg, 9mg, 14.5mg, and 17.2mg strengths. Unlike the Wegovy pill, Foundayo can be taken any time of day without food or water restrictions. ATTAIN-1 trial data showed approximately 12.4% average weight loss for participants who stayed on treatment (11.1% using the treatment-regimen estimand).
Price verified April 2026 via LillyDirect: $149/month at starter dose tiers. Higher doses: $199/month and $299/month depending on dose.
Route under $300: Pair with Ro ($39 first month, then $74/mo with annual prepay) for full telehealth, or with LillyDirect plus your own prescriber.
Wegovy® pill (oral semaglutide for weight loss)
FDA-approved December 2025FDA-approved December 2025 as the first oral GLP-1 for weight loss in adults. Clinical trials showed approximately 14% mean body weight loss over 64 weeks when combined with diet and exercise.
Price verified April 2026 via NovoCare Pharmacy: $149/month for the 1.5mg and 4mg doses. The 4mg price rises to $199/month after August 31, 2026. Higher doses price higher.
Route under $300: NovoCare Pharmacy direct with your own prescriber is the cleanest FDA-approved path.
Wegovy® injection (for starter-dose shoppers only)
Limited window — through June 30, 2026Price verified April 2026 via NovoCare Pharmacy: $199/month for 0.25mg and 0.5mg starter doses — through June 30, 2026. After June 30, 2026, price rises to $349/month. Clinical trial data (STEP program) shows approximately 15% mean body weight loss at the 2.4mg maintenance dose over 68 weeks.
Under-$300 reality check: Only the starter doses fit. Once you titrate past 0.5mg or the June 30, 2026 window closes, this path exceeds $300/month.
Zepbound® (FDA-approved, but above the $300 cap)
Above cap at every doseZepbound (tirzepatide) produces the strongest clinical weight-loss results of any medication in this class — approximately 20% mean body weight loss in SURMOUNT-1 at the 15mg dose. The cash-pay math doesn't fit this page:
- Zepbound vials through LillyDirect: $299/month (2.5mg), $399/month (5mg), $449/month (7.5–15mg)
- Adding any telehealth membership pushes the total above $300 at every dose
If you specifically want Zepbound and can expand your budget, Ro offers it with an insurance concierge that may reduce your effective cost dramatically if your insurance covers it.
A compliance note
FDA-approved medications (Wegovy, Ozempic, Zepbound, Mounjaro, Foundayo, Rybelsus) are manufactured under strict FDA quality controls and reviewed by the FDA for safety and effectiveness before reaching patients.
Compounded medications are prepared by licensed pharmacies under a clinician's prescription. They are not FDA-approved as finished products. We do not claim compounded GLP-1s contain the same active ingredient as FDA-approved versions, are clinically proven equivalents, or produce equivalent results. Those claims have been the focus of FDA enforcement actions against more than 30 telehealth companies in 2025–2026.
Compounded vs. FDA-approved under $300: the tradeoff
Reasons people choose compounded
- Lower cost at some price points
- More format options (drops, lozenges, sublingual)
- Flexibility around dosing that manufacturers don't offer
- HSA/FSA may apply when the prescription treats a physician-diagnosed condition
Reasons people choose FDA-approved
- The finished product has been reviewed by the FDA for safety, effectiveness, and quality
- Consistent dosing (no pharmacy-to-pharmacy variation)
- Clinical trial data supports the specific formulation you're taking
- Regulatory clarity — compounded rules shifted in 2025 and may shift again
What changed in 2025–2026
Timeline
- Feb 21, 2025FDA confirmed the semaglutide injection shortage was resolved
- Apr 22, 2025503A (state-licensed) pharmacies' deadline to wind down shortage-era semaglutide compounding
- May 22, 2025503B (outsourcing facility) deadline
- Dec 2025Wegovy pill FDA-approved — first FDA-approved oral GLP-1 for weight loss
- Feb–Mar 2026FDA issued warning letters to 30+ telehealth companies for misleading compounded GLP-1 marketing
- Apr 1, 2026Foundayo™ FDA-approved as the second FDA-approved oral GLP-1 for weight loss
If you're deciding right now: compounded GLP-1s are available through licensed pharmacies in many states when your clinician determines the compounded preparation is appropriate for you. The specific rules keep moving. That uncertainty is part of what you're accepting when you go the compounded route.
For more, see our guide to questions to ask before your GLP-1 telehealth consult — especially the compounded vs. FDA-approved section.
Stretching every dollar: HSA/FSA, annual prepay, and manufacturer programs
The HSA/FSA math most pages hide
The IRS treats prescribed medications for a specific diagnosed disease as qualified medical expenses. For most readers paying for GLP-1 treatment of obesity, type 2 diabetes, or a weight-related condition diagnosed by a physician, the medication typically qualifies — but confirm with your plan administrator, because general "weight loss" or wellness costs that aren't tied to a diagnosed condition don't qualify.
Eden + HSA/FSA worked example
$209/month at 36.65% combined effective tax rate:
~$132/month effective cost
$2,508 sticker cost → ~$1,589 effective over 12 months. Confirm eligibility with your plan administrator first.
Ro + Foundayo (annual prepay) + HSA/FSA
$273/month at 36.65% combined effective tax rate:
~$173/month effective cost
FDA-approved medication + full telehealth support. Confirm eligibility with your plan administrator first.
Annual prepay lowers membership fees
| Provider | Monthly billing | Annual prepay | Minimum commitment |
|---|---|---|---|
| Ro Body | $149/mo | As low as $74/mo effective ($888 upfront) | No minimum stated |
| Eden | $229/mo (month-to-month) | $209/mo (3-month plan) | 3-month plan |
| SHED | Starting at $199/mo | — | 2-month minimum regardless |
Manufacturer programs that stack
NovoCare Pharmacy (Novo Nordisk direct)
- Wegovy pill $149/mo (1.5mg and 4mg through 8/31/26)
- Wegovy injection $199/mo (0.25mg and 0.5mg through 6/30/26)
- Ozempic $199/mo (0.25mg and 0.5mg through 6/30/26)
LillyDirect (Eli Lilly direct)
- Foundayo from $149/mo at starter dose
- Zepbound vials from $299/mo (2.5mg)
- Manufacturer savings cards: Wegovy and Ozempic as low as $25/month with commercial insurance coverage
For more, see our guide to GLP-1 providers that accept HSA and FSA.
"I want to stretch my budget as far as it can go."
Check Ro's annual prepay option →At Foundayo's starter dose with annual prepay, effective HSA/FSA cost lands around $173/month for FDA-approved medication and full telehealth support.The 12-point verification checklist (use this before you pay)
Before you pay — run all 12
- 1.Does the provider require a real health intake? (Not "click here to enroll")
- 2.Does a licensed U.S. clinician review your case before prescribing?
- 3.Is the medication clearly labeled FDA-approved or compounded? No blurring — this is a legal and medical distinction.
- 4.If compounded: which specific pharmacy fills the prescription? Legitimate providers will tell you.
- 5.Is the month-two price shown on the pricing page, or only the month-one price?
- 6.Does the price change if your dose increases? Most do. Ask.
- 7.Is the care membership fee separate from the medication fee? Very common. Add them together.
- 8.Are labs required or optional — and included or extra?
- 9.Is shipping included, and does it use cold-chain for injections?
- 10.What happens if you cancel after the pharmacy has shipped? Often not refundable.
- 11.Is your state listed as available, in writing, before you pay?
- 12.Does the provider's marketing avoid misleading "generic" or "same as brand-name" claims? If it makes those claims, the FDA has been explicit that's a compliance problem.
Red flags that should stop you cold
"No prescription needed" (illegal for GLP-1 medications in the U.S.)
"Research use only" products marketed to consumers (also illegal as a workaround)
Guaranteed approval without a medical evaluation
Crypto-only or wire transfer payment (legitimate providers accept credit cards)
No physical U.S. business address
Marketing that implies FDA approval or FDA evaluation of compounded products
What we actually verified for this guide
Verified April 24, 2026
- Visited each provider's public pricing page and captured current pricing
- Cross-checked manufacturer-direct prices against NovoCare Pharmacy and LillyDirect
- Reviewed FDA warning letter records for every featured provider
- Verified the April 1, 2026 Foundayo FDA approval via Eli Lilly
- Verified the December 2025 Wegovy pill approval and current pricing windows
- Confirmed the NovoCare Wegovy pill 4mg window through August 31, 2026
- Confirmed the NovoCare Wegovy and Ozempic injection starter windows through June 30, 2026
- Confirmed the February 20, 2026 FDA warning letter to MEDVi (#721455) and September 9, 2025 warning letter to MyStart Health (#714755)
- Pulled Foundayo dose strengths, safety warnings, and ATTAIN-1 trial data from Eli Lilly's approval release
Needs re-verification before featuring more prominently
- SHED compounded semaglutide injection pricing (public conflict: $199 in comparison table vs. $299 on product card)
- MyStart Health current checkout pricing (public FAQ says $299/mo; older third-party reviews cite $149)
- Yucca Health 6-month plan all-in cost at checkout
- Direct Meds current pricing
- TrimRx billing and cancellation practices
- GoodRx Weight Loss current promotional pricing (the $199 promo ended March 31, 2026)
- Willow and bmiMD plan-length terms
What we left off this list (and why)
We want you to know what's not here and why. This is how we keep the ranking honest.
If you just lost your compounded program
This is a stressful transition. Your appetite management worked. The program disappeared. Now you're reading cost comparison pages trying not to fall backward. Three calm, practical next steps:
If you want to stay compounded at the lowest price
Eden's $209/month (3-month plan) is our cleanest broad pick. Your prior dose titration history means you can start at a mid-dose and stay there.
See Eden semaglutide pricing →If the 2025–2026 compounding shifts made you want FDA-approved status instead
NovoCare Pharmacy direct for the Wegovy® pill is $149/month at the 1.5mg and 4mg doses — if you have a prescriber. If you need telehealth support too, Ro + Foundayo™ with annual prepay is the path.
Check Ro + Foundayo →If you're not sure yet
Take the 60-second matching quiz. It's built for exactly this situation — budget-aware, medication-flexible, no sales pitch.
Take the free 60-second matching quizFAQ: GLP-1 under $300 per month
Each answer is written to stand alone — if it were quoted in isolation, it would still be complete and accurate.
Why we made this page
Weight Loss Provider Guide is an independent comparison resource for GLP-1 telehealth providers. We built this page because the existing "cheapest GLP-1" lists on the internet rank programs by the advertised starting price — which is almost never what you actually pay by month three.
The $300 Cap Test is our own framework. The Reality Matrix is our own verification work. The dose-escalation table is the one we wish every competitor published. We'd rather tell a reader "Eden is the cleanest pick, but it's not the cheapest sticker price, and here's why that trade is in your favor" than rank whichever program paid us most. If you removed every link on this page, would it still be the best resource on GLP-1 options under $300/month? We think so.
Still not sure which GLP-1 program is right for you?
Take the free 60-second matching quiz. Answer a few questions about your budget, insurance, medication preference, and comfort with compounded vs. FDA-approved options. We'll point you toward the safest next step. No signup. No hidden upsell.
Start the quizLast verified: · Next scheduled verification: May 2026 · Published by: Weight Loss Provider Guide — an independent comparison resource for GLP-1 telehealth providers.
Affiliate disclosure: This page contains affiliate links to Ro, Eden, MEDVi, SHED, and other providers. We may earn a commission when you click through. The rankings on this page are based on verified pricing, fit, and transparency — not on affiliate payout. Providers we excluded are named in the "What we left off this list" section above so you can judge for yourself.
Corrections: If any price, policy, or regulatory detail on this page is inaccurate, email [email protected]. We'll re-verify within 72 hours and publish a correction with the updated "Last verified" date.
Medical disclaimer: This content is for informational purposes only and is not medical advice. GLP-1 medications require a prescription from a licensed healthcare provider. Talk to your clinician before starting, switching, or stopping any GLP-1 medication.